MedPath

武汉久安药物研究院有限公司

Ownership
-
Established
2018-10-18
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Epinephrine Injection

Product Name
肾上腺素注射液
Approval Number
国药准字H20254444
Approval Date
Jun 3, 2025
NMPA

Metformin Hydrochloride Sustained-release Tablets(IV)

Product Name
盐酸二甲双胍缓释片(Ⅳ)
Approval Number
国药准字H20233457
Approval Date
Oct 13, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.